Efficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04)

NCT01971658 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

358

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Thalidomide®
DRUG: Cyclophosphamide
DRUG: Velcade®
DRUG: Dexaméthasone

Sponsor

Nantes University Hospital